Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option
Tata Mutual Fund · Managed by Rajat Srivastava
87strong
Latest NAV
₹38.4818
as of 18 Aug 2026
AUM
—
Expense ratio
0.64%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
87/100strong
Rank #137 of 1015 · top 13%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
2.06%
3M
6.20%
6M
10.16%
1Y
6.06%
3Y CAGR
19.13%
5Y CAGR
14.41%
Since incep.
13.46%
Fund details
- Fund manager
- Rajat Srivastava
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 92%
- Volatility (3Y)
- 15.3%
- Rating (external)
- —
Investment objective
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Stock holdings
Latest portfolio disclosure for this scheme.
No data yet
This fund hasn't disclosed a portfolio snapshot yet.